Terumo is a pioneer of biodegradable polymer technology. Terumo launched world’s first BP-DES in 2008. Terumo has the longest history in manufacturing BP-DES. Ultimaster™ is the most studied BP-DES in the world with over 50,000 patients in this long history.1,2 e-Ultimaster which is the key clinical program covering various patient characteristics is one of the largest BP-DES registry in the world. e-Ultimaster proved good performance of Ultimaster™.3
Ultimaster™ is designed by Terumo, a TRI pioneer. Ultimaster™’s delivery catheter is designed for TRI aimed at facilitating procedures done under an unstable back-up condition. The advanced shaft technology, flexible stent design and innovative tip provide less stressful treatment for you and your patients even in challenging complex lesions.
Ultimaster™ stent has a uniform open-cell platform. Ultimaster™ facilitates procedures in bifurcation lesions with its wider over-expansion capability, smooth side-branch access and reliable drug delivery.
- Comparison result with Biomatrix(Biosensors), Orsiro(biotronik) and Synergy(Boston scientific) based on information from only press release or product website at April 2020.
Total studied patient including Terumo sponsored trials and initiated research at April 2020.
M. Roffi, Insight in real-world PCI practice and clinical outcomes of patients treated with a new-generation DES presented at EuroPCR2019.
Based on CE mark approval date, Nobori was approved on January 16th, 2008.